Gabapentin Capsules

Gabapentin Capsules

Form: Capsules

Strength: 100 mg, 300 mg, 400 mg

Reference Brands: US: Neurontin®, Gralise®, Horizant® (ER); EU: Neurontin®, Gabantin®

Category: Antipsychotropic Drugs

Gabapentin capsules are approved by the FDA in the USA for treating partial-onset seizures (adjunct therapy) and postherpetic neuralgia. They are available in multiple strengths and require dose adjustment in renal impairment. In the European Union, gabapentin is authorized under brand names like Neurontin, primarily for epilepsy and peripheral neuropathic pain. Both regions classify gabapentin as a prescription-only medicine, with increasing regulatory monitoring due to its potential misuse and dependency. Pharmacovigilance includes CNS effects and drug interactions. Explore more forms, manufacturers, and sourcing options for Gabapentin Capsules at Pharmatradz.com.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Risperidone Long-Acting Injection

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes

Form: Long-Acting Injection

Reference Brands: Risperdal Consta(US &EU)

View Details Get Enquiry
Zuclopenthixol ong-acting IM Injection (Depot)

Strength: 200 mg/mL, 500 mg/mL

Form: Long-acting IM Injection (Depot)

Reference Brands: Clopixol Depot®(US)

View Details Get Enquiry
Zuclopenthixol Short-acting Intramuscular Injection

Strength: 50 mg/mL

Form: Short-acting Intramuscular Injection

Reference Brands: Clopixol-Acuphase®

View Details Get Enquiry
Zuclopenthixol tablets

Strength: 10 mg, 25 mg, 40 mg

Form: Oral Tablets

Reference Brands: Clopixol®(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

We use cookies to ensure you get the best experience. Learn more